Geert-Jan is Managing Partner at Forbion and has a leading role in the firm’s investment team and portfolio. He is an experienced life sciences investor who is led Forbion’s successful investments and served on the Boards of several Forbion portfolio companies, sometimes also in an executive capacity. In addition to his portfolio management activities, he …
Marc is Oxular’s Senior Medical Advisor and a practicing vitreoretinal surgeon, with more than 30 years of experience in ophthalmic drug and medical device development. Previously, he was the National Eye Institute’s representative responsible for defining the clinical trial of Foscarnet, the first approved drug to treat CMV retinitis in AIDS patients. He initiated the …
V-Bio Ventures finds, builds, and finances innovative life sciences companies. The company invests throughout Europe in start-up and early-stage companies with high growth potential as well as in technologies that provide transformational improvements in biopharmaceutical, pharmaceutical, and diagnostics markets. V-Bio Ventures works closely with Belgium-based VIB, one of the world’s premier life science institutes, with …
Rosetta is a specialist UK-based life science venture capital firm that invests globally to build leading healthcare companies and breakthrough technologies that can deliver benefits to human lives. We invest through direct secondary transactions to provide flexible liquidity solutions to investors or corporations
IP Group is a leading intellectual property commercialization company. It focuses on evolving great ideas, from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas – and the resulting businesses – by providing access to business-building expertise, capital (through its 100%-owned, FCA-authorized subsidiaries: IP Capital and Parkwalk …
Forbion is a leading European venture capital firm that helps companies bridge research and development through the team’s expertize in drug development and company building. Forbion is signatory to the United Nations Principles for Responsible Investment, further demonstrating its philosophy that investments in companies should positively impact the health and wellbeing of patients. It currently …
General
+44 (0)1865 636200
inquiries@oxular.com
Magdalen Centre
1 Robert Robinson Avenue
Oxford, OX4 4GA, UK
Limited company registered in
England and Wales
Registration No. 09331313
VAT No. GB 244 5883 81
Copyright Oxular Limited
Media
+1 617 895 9511
monique@thrustsc.com
Monique Allaire
Thrust
Follow us on
Limited company registered in England and Wales (Registration No. 09331313) VAT No. GB 244 5883 81
Copyright Oxular Limited
Website designed by Emerald Grove Studio
Website built by THRH Consulting